Kirkland Reps Baxter International In $380M Baxa Buy
Baxter said that accounting and other expenses for the all-cash transaction would cause a temporary drag of 3 to 5 cents per share on its fiscal 2012 earnings, but that the deal would be a net boon to its share price in 2013 and beyond.
Englewood, Colo.-based Baxa specializes in products that improve the efficiency and accuracy of IV and...
Already a subscriber? Click here to login